Clinical trials: Penile/Perianal/Perineal Cancer

Penile/Perineal /Perianal Intraepithelial Neoplasia, Anal Intraepithelial Neoplasia

A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males

• Active, not recruiting
• Age: 18 to 45 years
• Phase 3
• Vaccines

This phase III clinical trial was designed to evaluate the efficacy, immunogenicity and safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) manufactured by Xiamen…

Conditions

Penile/Perineal /Perianal Intraepithelial Neoplasia, Anal Intraepithelial Neoplasia, Penile/Perianal/Perineal Cancer, Anal Cancer

Trial name

NCT06866574

Testing

Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.coli), Aluminum Adjuvant

Where

4 sites in China

Volunteers

9,300 people, healthy volunteers welcome

Sponsor

Xiamen University